Cargando…
Two case reports of acquired haemophilia A as complications of alemtuzumab treatment for multiple sclerosis
OBJECTIVE: To describe the case histories of two patients who developed acquired haemophilia A following treatment with alemtuzumab for multiple sclerosis. RESULTS: Two patients, a 48-year-old woman and a 31-year-old woman, developed acquired haemophilia A 21 months after their second doses of alemt...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871705/ https://www.ncbi.nlm.nih.gov/pubmed/33681807 http://dx.doi.org/10.1136/bmjno-2020-000095 |